BMC's Department of Kidney Medicine takes care of approximately nine thousand adults with various types of kidney disease each year. Our kidney doctors (nephrologists) are experts in multiple types of kidney diseases, including end-stage renal disease (ESRD) requiring dialysis or transplantation and other diseases involving the kidneys such as glomerulonephritis, polycystic kidney disease, and acute kidney injury.
BMC named high performing in kidney care by U.S. News & World Report
Award-Winning Doctors
Our physicians have been named to Boston Magazine’s “Top Docs” list for multiple years.
Nationally Honored Leadership
The National Kidney Foundation of New England recognized our department chief for outstanding contributions to kidney care.
High-Rated Dialysis Care
Our dialysis clinic earned a four-star quality rating from the Centers for Medicare and Medicaid Services.
Location and Contact
Kidney Medicine Department
Monday–Friday 8 a.m. to 5 p.m.
Related Programs and Clinics
Adult Primary Care
Comprehensive Hypertension Center
Lupus Clinic
Nephrology Fellowship
BMC's nephrology fellowship program provides comprehensive clinical and research training in all aspects of nephrology. Our multifaceted training takes place at multiple sites around Boston, including BMC, the Boston VA Health System, and Davita Boston Dialysis. We offer a clinical track, clinical and research track, and research track.
Research
Kidney Research Overview
Investigators in the Section of Kidney Medicine at BMC have conducted groundbreaking research that have influenced the way kidney disease is diagnosed and treated around the world. Active areas of research include glomerular disease pathobiology, mechanisms of autoimmunity, kidney physiology, acute kidney injury, chronic kidney disease, and hemodialysis vascular access, to name just a few.
Kidney Medicine Clinical Trials
BMC researchers are finding innovative new ways to treat kidney diseases. While we enroll any and all eligible patients in clinical trials, BMC physicians are leaders in the enrollment of under-represented minorities in clinical trials.